
    
      The first five patients receive SPC3 daily for 3 weeks. If that dose is tolerated, the dose
      is increased and given to the next 5 patients for 3 weeks. The remaining ten patients receive
      a dose of SPC3 based on response to the previous two dose levels. Patients are followed
      through day 28.
    
  